Crossref
A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis
Clinical Laboratory · 2023
DOI: 10.7754/clin.lab.2022.220413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2023. Verfasst von Shuyun Li und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Carcinoma, HepatocellularLiver NeoplasmsHepatitis BHumansalpha-FetoproteinsBiomarkersBiomarkers, TumorHepatitis B virusProthrombinROC Curve
Substanzen
alpha-FetoproteinsBiomarkersBiomarkers, TumorProthrombin
Zitieren
APA
Li, S., Liu, D., & Wang, Q. (2023). A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2022.220413
Vancouver
Li S, Liu D, Wang Q. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2022.220413
BibTeX
@article{Li2023,
author = {Li, Shuyun and Liu, Dingbin and Wang, Qiang},
title = {A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis},
journal = {Clinical Laboratory},
year = {2023},
doi = {10.7754/clin.lab.2022.220413}
}
EUVIMED